Clinical Trials Directory

Trials / Completed

CompletedNCT01261078

The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine

The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine for Spinal Anesthesia in Total Knee Replacement Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Seoul Medical Center · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Intrathecal epinephrine has been known to increase the duration of spinal anesthesia, or increase the quality of anesthesia. However, there is still a controversy, and the mechanism of epinephrine is recently suggested as a modulator of pain information in the spinal cord. Therefore, the investigators try to investigate the dose sparing effect of intrathecal epinephrine for spinal anesthesia with bupivacaine.

Detailed description

For patient undergoing total knee replacement arthroplasty, patients injected intrathecally with bupivacaine 8 mg were compared with those with bupivacaine 8 mg with 25 mcg of epinephrine, bupivacaine 8 mg with 50 mcg of epinephrine, and those with bupivacaine 8 mg with 100 mcg of epinephrine. The investigators compared the characteristics of spinal anesthesia including the quality and complication of spinal anesthesia. The researchers investigated whether intrathecal dose of epinephrine can reduce bupivacaine requirement and this effect is dependent on the dose of epinephrine.

Conditions

Interventions

TypeNameDescription
DRUGPlacebointrathecal 8 mg of bupivacaine only
DRUGepinephrine 25intrathecal 8 mg of bupivacaine mixed with 25 mcg of epinephrine
DRUGEpinephrine 50intrathecal 8 mg of bupivacaine mixed with 50 mcg of epinephrine
DRUGepinephrine 100intrathecal 8 mg of bupivacaine mixed with 0.1 mg of epinephrine
DRUGEpi 200intrathecal bupivacaine 8 mg with 200 mcg of epinephrine

Timeline

Start date
2010-12-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-12-16
Last updated
2011-07-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01261078. Inclusion in this directory is not an endorsement.